Qualcomm (NASDAQ:QCOM) CAO Sells 98 Shares of Stock
Qualcomm Incorporated (NASDAQ:QCOM – Get Free Report) CAO Patricia Grech sold 98 shares of the business’s stock in a transaction dated Friday, October 2nd. The stock was sold at an average price of $186.55, for a total transaction of $18,281.90. The transaction was disclosed in a legal filing with the SEC, which is available through […]
Verastem (NASDAQ:VSTM) CEO Sells $352,968.00 in Stock
Verastem, Inc. (NASDAQ:VSTM – Get Free Report) CEO Dan Paterson sold 44,121 shares of Verastem stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $8.00, for a total value of $352,968.00. Following the transaction, the chief executive officer owned 652,712 shares of the company’s stock, […]
AvePoint (NASDAQ:AVPT) Insider Sells 10,000 Shares of Stock
AvePoint, Inc. (NASDAQ:AVPT – Get Free Report) insider Brian Brown sold 10,000 shares of AvePoint stock in a transaction on Wednesday, September 30th. The shares were sold at an average price of $14.11, for a total value of $141,100.00. Following the sale, the insider directly owned 364,604 shares in the company, valued at $5,144,562.44. The […]
PTC Therapeutics (NASDAQ:PTCT) Director Sells 12,000 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) Director Glenn Md Phd Steele, Jr. sold 12,000 shares of the firm’s stock in a transaction dated Wednesday, September 30th. The shares were sold at an average price of $65.16, for a total value of $781,920.00. Following the sale, the director owned 22,500 shares in the company, […]
Emerson Electric (NYSE:EMR) Price Target Raised to $174.00
Emerson Electric (NYSE:EMR – Free Report) had its price objective raised by Deutsche Bank Aktiengesellschaft from $169.00 to $174.00 in a research note issued to investors on Wednesday. The firm currently has a hold rating on the industrial products company’s stock. Several other research analysts have also weighed in on the company. Wells Fargo & […]
Roivant Sciences (NASDAQ:ROIV) CEO Sells 200,000 Shares of Company Stock
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) CEO Eric Venker sold 200,000 shares of Roivant Sciences stock in a transaction on Wednesday, September 30th. The shares were sold at an average price of $36.62, for a total value of $7,324,000.00. Following the sale, the chief executive officer directly owned 1,599,154 shares of the company’s […]
Stifel Nicolaus Cuts MongoDB (NASDAQ:MDB) Price Target to $385.00
MongoDB (NASDAQ:MDB – Free Report) had its target price cut by Stifel Nicolaus from $465.00 to $385.00 in a research note issued to investors on Wednesday morning, Marketbeat Ratings reports. They currently have a buy rating on the stock. A number of other brokerages have also commented on MDB. Robert W. Baird raised their target […]
Docusign (NASDAQ:DOCU) CRO Paula Hansen Sells 3,300 Shares of Company Stock
Docusign Inc. (NASDAQ:DOCU – Get Free Report) CRO Paula Hansen sold 3,300 shares of Docusign stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $68.81, for a total value of $227,073.00. Following the completion of the sale, the executive directly owned 106,557 shares of the company’s stock, […]
Morgan Stanley Cuts Ferrari (NYSE:RACE) Price Target to $456.00
Ferrari (NYSE:RACE – Free Report) had its price target lowered by Morgan Stanley from $460.00 to $456.00 in a report issued on Wednesday morning, Marketbeat Ratings reports. The brokerage currently has an overweight rating on the stock. Several other equities research analysts have also recently weighed in on the stock. Evercore reiterated an “outperform” rating […]
BioCryst Pharmaceuticals (NASDAQ:BCRX) Price Target Raised to $13.00
BioCryst Pharmaceuticals (NASDAQ:BCRX – Free Report) had its target price boosted by JPMorgan Chase & Co. from $12.00 to $13.00 in a report issued on Wednesday morning,Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. Several other research analysts have also recently weighed in on the stock. Royal Bank Of Canada […]
Natera (NASDAQ:NTRA) Stock: Insider Solomon Moshkevich Sells 3,000 Shares
Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Solomon Moshkevich sold 3,000 shares of the stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $414.22, for a total value of $1,242,660.00. Following the transaction, the insider directly owned 106,914 shares in the company, valued at $44,285,917.08. The […]
XPENG Inc. Sponsored ADR (NYSE:XPEV) Stock Has Average Price Target of $22.09
Shares of XPENG Inc. Sponsored ADR (NYSE:XPEV – Get Free Report) have earned an average rating of “Hold” from the eleven brokerages that are presently covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and […]
Xometry (NASDAQ:XMTR) Stock: Insider Randolph Altschuler Sells 10,000 Shares
Xometry, Inc. (NASDAQ:XMTR – Get Free Report) Director Randolph Altschuler sold 10,000 shares of the stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $104.04, for a total value of $1,040,400.00. Following the completion of the sale, the director owned 541,270 shares of the company’s stock, valued […]
Insider Selling: TransUnion (NYSE:TRU) EVP Sells 250 Shares of Company Stock
TransUnion (NYSE:TRU – Get Free Report) EVP Mohamed Abdelsadek sold 250 shares of TransUnion stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $62.29, for a total transaction of $15,572.50. Following the completion of the transaction, the executive vice president owned 53,181 shares in the company, valued […]
Oramed Pharmaceuticals (NASDAQ:ORMP) COO Sells 30,000 Shares of Company Stock
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report) COO Joshua Hexter sold 30,000 shares of Oramed Pharmaceuticals stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $4.51, for a total transaction of $135,300.00. Following the sale, the chief operating officer directly owned 1,328,130 shares of the company’s […]
Royal Bank Of Canada Cuts TFI International (NYSE:TFII) Price Target to $144.00
TFI International (NYSE:TFII – Free Report) had its price objective reduced by Royal Bank Of Canada from $171.00 to $144.00 in a research note issued to investors on Wednesday morning, Marketbeat reports. Royal Bank Of Canada currently has an outperform rating on the stock. Several other research firms have also recently issued reports on TFII. […]
AnaptysBio (NASDAQ:ANAB) Director Hollings Renton Sells 5,000 Shares of Company Stock
AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) Director Hollings Renton sold 5,000 shares of the firm’s stock in a transaction dated Thursday, October 1st. The shares were sold at an average price of $49.87, for a total transaction of $249,350.00. Following the completion of the sale, the director owned 10,995 shares of the company’s stock, […]
Rubrik (NYSE:RBRK) Stock: Insider John Wendell Thompson Sells 11,000 Shares
Rubrik, Inc. (NYSE:RBRK – Get Free Report) Director John Thompson sold 11,000 shares of Rubrik stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $115.69, for a total transaction of $1,272,590.00. Following the completion of the transaction, the director directly owned 8,362 shares in the […]
Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Has Average Target Price of $21.57
Shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, six have assigned a buy recommendation and one has given a strong buy recommendation […]
Stoke Therapeutics (NASDAQ:STOK) Stock: Insider Barry Ticho Sells 1,051 Shares
Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) insider Barry Ticho sold 1,051 shares of Stoke Therapeutics stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $26.16, for a total transaction of $27,494.16. Following the sale, the insider directly owned 19,059 shares of the company’s stock, valued […]
Xeris Biopharma (NASDAQ:XERS) Stock: Insider Steven Pieper Sells 5,000 Shares
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) insider Steven Pieper sold 5,000 shares of the company’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $9.41, for a total value of $47,050.00. Following the completion of the sale, the insider directly owned 1,351,053 shares in […]
Wells Fargo & Company Cuts ATI (NYSE:ATI) Price Target to $240.00
ATI (NYSE:ATI – Free Report) had its price target lowered by Wells Fargo & Company from $275.00 to $240.00 in a research note released on Wednesday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the basic materials company’s stock. A number of other research analysts have also issued reports on ATI. Susquehanna […]
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Stock Has Consensus Price Target of $11.33
Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have issued a buy rating and three have given a strong buy rating to […]
Insider Selling: Warby Parker (NYSE:WRBY) CEO Sells $2,769,000.00 in Stock
Warby Parker Inc. (NYSE:WRBY – Get Free Report) CEO Neil Blumenthal sold 100,000 shares of the business’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $27.69, for a total transaction of $2,769,000.00. Following the completion of the transaction, the chief executive officer owned 36,020 shares of […]
Scotiabank Reiterates C$17.00 Price Target for Tamarack Valley Energy (TSE:TVE)
Scotiabank set a C$17.00 price target on Tamarack Valley Energy (TSE:TVE – Free Report) in a report published on Wednesday, MarketBeat reports. The brokerage currently has a sector outperform rating on the stock. Several other equities research analysts have also issued reports on the stock. Desjardins lifted their price target on shares of Tamarack Valley […]
National Bank Financial Analysts Give Cenovus Energy (TSE:CVE) a C$60.00 Price Target
National Bank Financial set a C$60.00 price objective on Cenovus Energy (TSE:CVE – Free Report) (NYSE:CVE) in a research note issued to investors on Wednesday morning,BayStreet reports. The brokerage currently has an outperform rating on the stock. Several other equities analysts have also recently commented on CVE. Royal Bank Of Canada increased their target price […]
PennyMac Mortgage Investment Trust (NYSE:PMT) CAO Sells 2,444 Shares of Company Stock
PennyMac Mortgage Investment Trust (NYSE:PMT – Get Free Report) CAO Gregory Hendry sold 2,444 shares of the company’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $7.86, for a total transaction of $19,209.84. Following the sale, the chief accounting officer directly owned 4,886 shares in the […]
Prairie Operating (NASDAQ:PROP) Stock: Insider Richard Frommer Purchases 28,000 Shares
Prairie Operating Co. (NASDAQ:PROP – Get Free Report) Director Richard Frommer bought 28,000 shares of the stock in a transaction on Thursday, September 3rd. The shares were bought at an average price of $0.45 per share, for a total transaction of $12,600.00. Following the completion of the transaction, the director directly owned 333,372 shares of […]
B2Gold Corp. (TSE:BTO) Stock Has Consensus Target Price of C$9.33 According to Analysts
B2Gold Corp. (TSE:BTO – Get Free Report) (NYSE:BTG) has earned an average recommendation of “Buy” from the eight research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, four have given a buy recommendation and three have given a strong buy recommendation to the […]
Wells Fargo & Company Cuts Carpenter Technology (NYSE:CRS) Price Target to $430.00
Carpenter Technology (NYSE:CRS – Free Report) had its target price reduced by Wells Fargo & Company from $540.00 to $430.00 in a report published on Wednesday,Benzinga reports. They currently have an equal weight rating on the basic materials company’s stock. A number of other equities research analysts have also issued reports on the company. Susquehanna […]
last updated on 3 Oct 06:57